Expert Analysis

Chemotherapy and Targeted Agents

Source: CCO Independent Conference Coverage of the 2006 Annual San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Chemotherapy and Targeted Agents

Faculty:
Edith A. Perez, MD Nicholas J. Robert, MD Joseph A. Sparano, MD

CME CREDIT INFORMATION

Release Date: 02/27/07

Expiration Date: 02/26/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss results from clinical trial studies using chemotherapy in combination with targeted agents for the treatment of early-stage breast cancer
Describe optimal treatment regimens for treating early-stage breast cancer patients
Recall the safety profiles associated with the use of targeted agents

Topics covered include:

Early Breast Cancer Trialists’ Collaborative Group Overview
Combination Neoadjuvant Lapatinib/Paclitaxel
Neoadjuvant Cisplatin in Triple Negative Breast Cancer
Results of the German Gepartrio Study
HER2/neu E75 Vaccine
HER2 and Response to Chemotherapy
Breast Cancer International Research Group 006
Eastern Cooperative Oncology Group E2198 Trial
Dose-Dense Chemotherapy Plus Trastuzumab
Dose-Dense Sequential Chemotherapy
MA.21 Trial
The TAnDEM Trial

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.